Inflammatory markers in AD and MCI patients with different biomarker profiles-interpretation of serum and CSF levels

Authors :: Marinus A. Blankenstein
Robert Veerhuis
Miranda G. Dik
Niki S.M. Schoonenboom
Alie Schuitemaker
Cees Jonker
Philip Scheltens
C. Erik Hack
Neuroscience Campus Amsterdam - Neurodegeneration
EMGO+ - Quality of Care
Neurology
General practice
Clinical chemistry
Psychiatry
EMGO - Quality of care
NCA - Neurodegeneration
Source :: Neurobiology of Aging, 31(9), 1655-1655. Elsevier Inc., Schuitemaker, A, Dik, M G, Veerhuis, R, Scheltens, P, Schoonenboom, S N M, Hack, C E, Blankenstein, M A & Jonker, C 2010, ' Inflammatory markers in AD and MCI patients with different biomarker profiles-interpretation of serum and CSF levels ', Neurobiology of Aging, vol. 31, no. 9, pp. 1655-1655 . https://doi.org/10.1016/j.neurobiolaging.2010.02.017
Publication Year :: 2010
Abstract: 0 d Authors’ response to commentaries Inflammatory markers in AD and MCI patients with different biomarker profiles—interpretation of serum and CSF levels Alie Schuitemaker*, Miranda G. Dik, Robert Veerhuis, Philip Scheltens, Niki S.M. Schoonenboom, C. Erik Hack, Marinus A. Blankenstein, Cees Jonker a Department of Neurology, Alzheimer’s Center, VU University Medical Center, 1007 MB Amsterdam, the Netherlands b EMGO Institute, VU University Medical Center, 1007 MB Amsterdam, the Netherlands c www.elsevier.com/locate/neuaging

Subjects :: Oncology
Aging
medicine.medical_specialty
Pathology
business.industry
General Neuroscience
Internal medicine
medicine
Biomarker (medicine)
University medical
Neurology (clinical)
Geriatrics and Gerontology
business
Developmental Biology

Tools